Marumax (Tamsulosin Hydrochloride, Dutasteride)

Tamsulosin blocks alpha‑1 receptors in the prostate and bladder neck, reducing muscle tone and easing urine passage. Dutasteride inhibits both type I and type II 5‑alpha‑reductase enzymes, lowering dihydrotestosterone levels and gradually decreasing prostate volume. Together they address both the dynamic and static components of BPH.

The dosage of Marumax is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and concomitant medications. Healthcare professionals should follow local prescribing guidelines and adjust the regimen as needed.

Marumax is intended for adult male patients with BPH and is not indicated for use in pregnancy or breastfeeding. There is no clinical data supporting safety in these populations, and the product should be avoided in women who are pregnant, may become pregnant, or are nursing.

To request Marumax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with monotherapy options, Marumax offers a dual mechanism—alpha‑blockade for rapid symptom relief and 5‑alpha‑reductase inhibition for long‑term prostate size reduction. This combination can provide faster improvement than dutasteride alone and greater prostate shrinkage than tamsulosin alone, though individual response varies.

Marumax tablets should be stored at room temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use after the expiry date printed on the packaging.

Marumax is taken orally, usually once daily, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush, chew, or split the tablet unless specifically instructed.

Serious risks include severe hypotension, syncope, priapism, and allergic reactions such as rash, angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience fainting, prolonged painful erections, or signs of a severe allergic response.

Marumax is contraindicated in patients with known hypersensitivity to tamsulosin, dutasteride, or any excipients. It should also be avoided in men with severe liver impairment, those taking potent CYP3A4 inhibitors without medical supervision, and in women, especially during pregnancy or lactation.